Information for the public
Healthcare Professionals
AMD audit report summary for patients
To find out more about the findings of the second year of the Age-related Macular Degeneration (AMD) Audit, please click below.
Second NOD Age-related macular degeneration audit annual report
The audit report presents an analysis of data submitted by 66 centres across the UK and involving 26,847 eyes of 24,300 patients with neovascular age-related macular degeneration (NvAMD) who started their treatment between April 2021 and March 2022. Treatment providers can use the information to compare outcomes with national aggregates and local peers, identify key clinical care processes and share best practice.